Paolo Carlini
- Oncology top 1%
- Cancer Treatment and Pharmacology 34
- HER2/EGFR in Cancer Research 16
- Colorectal Cancer Treatments and Studies 15
- Pancreatic and Hepatic Oncology Research 12
- Cancer Research top 2%
- Breast Cancer Treatment Studies 20
-
- Prostate Cancer Treatment and Research 16
- Lung Cancer Treatments and Mutations 12
- Otorhinolaryngology top 5%
- Gastroenterology top 5%
-
- Estrogen and related hormone effects 16
- Co-authors
- Francesco CognettiDiana GiannarelliEmilio BriaMichèle MilellaEnzo Maria RuggeriE. TerzoliAlessandra FabiG. Ferretti
- Journals
- Journal of Clinical Oncology (29 papers)JNCI Journal of the National Cancer Institute (1 paper)Cancer (13 papers)
- Partner nations
- ItalyMalaysiaUnited States
In The Last Decade
Paolo Carlini
121 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 133
- Oncology 1.7k
- Cancer Research 774
- Pulmonary and Respiratory Medicine 1.0k
- Otorhinolaryngology 133
- Gastroenterology 89
Countries citing papers authored by Paolo Carlini
This map shows the geographic impact of Paolo Carlini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Carlini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Carlini more than expected).
Fields of papers citing papers by Paolo Carlini
This network shows the impact of papers produced by Paolo Carlini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Carlini. The network helps show where Paolo Carlini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paolo Carlini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 5 | |
| 2 | 2015 | 0 | |
| 3 | 2015 | 103 | |
| 4 | Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule. | 2008 | 8 |
| 5 | 2008 | 42 | |
| 6 | 2008 | 47 | |
| 7 | 2006 | 15 | |
| 8 | 2006 | 26 | |
| 9 | 2006 | 53 | |
| 10 | 2005 | 9 | |
| 11 | 2005 | 21 | |
| 12 | 2004 | 47 | |
| 13 | 2003 | 10 | |
| 14 | 2003 | 17 | |
| 15 | 2002 | 4 | |
| 16 | 1996 | 8 | |
| 17 | 1994 | 16 | |
| 18 | 1990 | 3 | |
| 19 | 1989 | 9 | |
| 20 | Combination chemotherapy (CABO) prior to radiation for locally advanced inoperable squamous cell carcinoma of the head and neck | 1984 | 1 |
About Paolo Carlini
Paolo Carlini is a scholar working on Oncology, Cancer Research and Otorhinolaryngology, having authored 125 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (34 papers), Breast Cancer Treatment Studies (20 papers), Estrogen and related hormone effects (16 papers), HER2/EGFR in Cancer Research (16 papers), Prostate Cancer Treatment and Research (16 papers), Colorectal Cancer Treatments and Studies (15 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (774 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Paolo Carlini has collaborated with scholars based in Italy, Malaysia and United States. Frequent co-authors include Francesco Cognetti, Diana Giannarelli, Emilio Bria, Michèle Milella, Enzo Maria Ruggeri, E. Terzoli, Alessandra Fabi, G. Ferretti, Paola Papaldo and Federica Cuppone. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.